Wawrzyniec Lawrence Dobrucki is currently a senior research scientist at Beckman Institute and holds adjunct assistant professor position in the U of I Department of Bioengineering. He directs the Molecular Imaging Laboratory in Biomedical Imaging Center (BIC).
His expertise is in molecular multimodality imaging, and his fields of professional interests include development of novel targeted microSPECT/PET-CT imaging strategies to assess myocardial and peripheral angiogenesis in animal models of disease including diabetes, standardization of small animal imaging protocols, and validation of novel SPECT/PET radiotracers and CT contrast agents.
Dr. Dobrucki received his Ph.D. in Chemistry from Ohio University, Athens, OH in 2003, and M.Sc. degree in Bioengineering from Technical University of Wroclaw, Poland and Technical University of Hamburg, Germany. Prior to joining Beckman Institute in 2010, Dr. Dobrucki was a junior faculty member at Yale University School of Medicine where he managed small animal imaging facility in the Department of Cardiology in the Section of Cardiovascular Medicine.
How did you first hear about nanoHUB?
What is the primary purpose of your visit to nanoHUB?